Proteomic biomarkers of emphysema-predominant and non-emphysema-predominant chronic obstructive pulmonary disease
Open Access
- 12 June 2025
- journal article
- Published by Elsevier in EBioMedicine
- Vol. 117, 105800
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Mental Health
- National Heart Lung and Blood Institute
This publication has 69 references indexed in Scilit:
- Differential Association of COPD Subtypes With Cardiovascular Events and COPD ExacerbationsChest, 2024
- Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary diseaseEBioMedicine, 2022
- An Integrative Genomic Strategy Identifies sRAGE as a Causal and Protective Biomarker of Lung FunctionChest, 2022
- Genetic variation in genes regulating skeletal muscle regeneration and tissue remodelling associated with weight loss in chronic obstructive pulmonary diseaseJournal of Cachexia, Sarcopenia and Muscle, 2021
- KRT1 gene silencing ameliorates myocardial ischemia–reperfusion injury via the activation of the Notch signaling pathway in mouse modelsJournal of Cellular Physiology, 2018
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- Relationship of emphysema and airway disease assessed by CT to exercise capacity in COPDRespiratory Medicine, 2010
- Proteomics-Based Biomarkers in Chronic Obstructive Pulmonary DiseaseJournal of Proteome Research, 2010
- Cardiovascular Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy RevisitedJACC, 2006
- Collagenase expression in the lungs of transgenic mice causes pulmonary emphysemaCell, 1992